- Home
- TYL vs FMS Comparison
TYL vs FMS Comparison
Compare TYL & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TYL | FMS |
|---|---|---|
| Founded | 1966 | 1996 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Misc Health and Biotechnology Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.5B | 14.2B |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | TYL | FMS |
|---|---|---|
| Price | $321.89 | $23.22 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 11 | 2 |
| Target Price | ★ $474.36 | $30.00 |
| AVG Volume (30 Days) | ★ 423.2K | 387.7K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 2.40% |
| EPS Growth | ★ 19.01 | N/A |
| EPS | ★ 7.20 | N/A |
| Revenue | ★ $493,101,000.00 | N/A |
| Revenue This Year | $9.59 | $0.45 |
| Revenue Next Year | $9.70 | $3.76 |
| P/E Ratio | $44.59 | ★ $15.62 |
| Revenue Growth | ★ 18.35 | N/A |
| 52 Week Low | $283.72 | $20.96 |
| 52 Week High | $621.34 | $30.46 |
Technical Indicators
Market Signals| Indicator | TYL | FMS |
|---|---|---|
| Relative Strength Index (RSI) | 38.08 | 54.62 |
| Support Level | $283.72 | $22.50 |
| Resistance Level | $365.00 | $23.36 |
| Average True Range (ATR) | 11.09 | 0.37 |
| MACD | -1.31 | 0.17 |
| Stochastic Oscillator | 23.19 | 67.20 |
Price Performance
Historical ComparisonAbout TYL Tyler Technologies Inc.
Tyler Technologies provides a full suite of software solutions and services that address the needs of cities, counties, schools, courts and other local government entities. The company's three core products are Munis, which is the core ERP system, Odyssey, which is the court management system, or CMS, and payments. The company also provides a variety of add-on modules and offers outsourced property tax assessment services.
About FMS Fresenius Medical Care AG
Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.